IMMUNE RESPONSE DRUG CONJUGATES: CARBON-14 LABELING NECESSITIES

Abstract

Despite recent advances in early detection and treatment, prostate cancer is the most common cancer and the second leading cause of cancer-related deaths in developed countries. Prostate cancer patients having a limited number of treatment options such as radiotherapy, cytotoxic chemotherapy etc. Although results of all approaches are showing beneficial effects, but without long term survival benefit. A recent development in the field of cancer treatment named as gene therapy comes in existence with promise of prostate cancer treatment. It is an emerging field against not only prostate cancer but for all types of cancers. With advancement of basic research and gene therapy technology, no doubt it may be the best future cancer treatment with the use of genetic engineering and clinical trials. In this review we tried to conclude the importance of the gene therapy in prostate cancer with novel and unique characteristics and with promise to cure as the hope for management of the prostate cancer.

KEYWORDS: Gene Therapy, Carcinoma Prostate, Gene Transfer, Immunotherapy, Oncolytic Virotherapy.